M
Michael Hughes
Researcher at Royal Hallamshire Hospital
Publications - 615
Citations - 26328
Michael Hughes is an academic researcher from Royal Hallamshire Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 74, co-authored 531 publications receiving 24066 citations. Previous affiliations of Michael Hughes include Royal College of Physicians & St Thomas' Hospital.
Papers
More filters
Proceedings ArticleDOI
An optical coherence tomography investigation of materials defects in ceramic fixed partial dental prostheses
Cosmin Sinescu,Meda Lavinia Negrutiu,Michael Hughes,Adrian Bradu,Carmen Todea,Mihai Rominu,Philippe L. Laissue,Adrian Gh. Podoleanu +7 more
TL;DR: The capability of optical coherence tomography (OCT) in detection and analysis of possible material defects in metal-ceramic and integral ceramic fixed partial dentures is evaluated.
Journal ArticleDOI
Digital ulcers: should debridement be a standard of care in systemic sclerosis?
Michael Hughes,Michael Hughes,Begonya Alcacer-Pitarch,Begonya Alcacer-Pitarch,Yannick Allanore,Murray Baron,Francesco Boin,Cosimo Bruni,Lorinda Chung,Francesco Del Galdo,Francesco Del Galdo,Christopher P. Denton,Marco Matucci-Cerinic +12 more
TL;DR: Debridement might be the missing component in optimising the management of digital ulcers and it is proposed that the approach should be rigorously investigated as a standard of care in this common complication of systemic sclerosis.
Proceedings ArticleDOI
Fixed partial dentures investigated by optical coherent tomography
Cosmin Sinescu,Meda Lavinia Negrutiu,Carmen Todea,Michael Hughes,Florin Tudorache,Adrian Gh. Podoleanu +5 more
TL;DR: En-face OCT has proven as a valuable non invasive method to investigate fixed partial prostheses before their insertion in the oral cavity.
Journal ArticleDOI
A systematic review of internet‐based information on dermatomyositis and polymyositis
TL;DR: Assessment of the readability and quality of internet‐based information on dermatomyositis and polymyositis in patients with rheumatic diseases found it to be suitable for use in clinical practice.
Journal ArticleDOI
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection
David Katzenstein,Michael Hughes,Mary Albrecht,S. H. Liou,Robert L. Murphy,Henry H. Balfour,Michael F. Para,Scott M. Hammer +7 more
TL;DR: To optimize nucleoside reverse transcriptase inhibitor (nRTI) antiretroviral therapy, 137 subjects who had been treated with didanosine monotherapy for more than 3 years in the AIDS Clinical Trials Group (ACTG) 175 study were randomized to zidovudine andDidanosine (dual therapy) or zidvudine, didanosines, and lamivudine (triple therapy).